Mackenzie Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Mackenzie Financial’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,877	Closed	-$267K	–	1532
2021 Q4	$267K	Buy	+2,877	New	+$190K	﹤0.01%	1200
2020 Q2	–	Sell	-21,198	Closed	-$890K	–	1168
2020 Q1	$890K	Buy	+21,198	New	+$972K	﹤0.01%	672

Mackenzie Financial's ARNA Position: Q1 2022 in Review

Mackenzie Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,877 shares — an estimated $267K sold.

Mackenzie Financial first reported a position in ARNA in Q1 2020 and held it in 2 quarters. The position peaked at $890K in Q1 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Mackenzie Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Mackenzie Financial sold 2,877 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $267K.
Mackenzie Financial first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 2 quarters.
Mackenzie Financial's Arena Pharmaceuticals Inc position peaked at $890K in Q1 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Mackenzie Financial's 13F filing for Q1 2022, filed 13 May 2022.